Translation of [177Lu]Lu-Ibu-DAB-PSMA to a clinical setting is, thus, warranted to shed light on its utility to treat prostate cancer patients and its future applicability in nuclear oncology. The gene discussed is FOLH1; the disease is prostate cancer.